Assessing heart health during COPD flare-ups to improve care
Early Cardiovascular Risk Assessment of Patients With COPD During Respiratory Exacerbation for the Identification and Treatment of Cardiovascular Comorbidity
This study is testing whether adding a heart doctor to the care of people hospitalized for COPD flare-ups can help improve their overall health and treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Tel-Aviv Sourasky Medical Center Government |
| Locations | 1 site (Tel Aviv) |
| Trial ID | NCT06723795 on ClinicalTrials.gov |
What this trial studies
This study involves patients hospitalized for exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Participants will be randomly assigned to two groups: one receiving care solely from a pulmonologist and the other receiving additional evaluation from a cardiologist. Both groups will complete a questionnaire and receive follow-up assessments over the next year to monitor changes in treatment, new cardiovascular issues, COPD flare-ups, and mortality. The goal is to improve diagnosis and treatment by addressing potential cardiovascular comorbidities during COPD exacerbations.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-75 with documented COPD who can provide informed consent.
Not a fit: Patients under 18, those unable to provide consent, or with unstable concurrent diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better management of both COPD and cardiovascular diseases, improving patient outcomes.
How similar studies have performed: Other studies have shown that addressing comorbidities like cardiovascular diseases during COPD management can lead to improved patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Documented COPD (based on lung function tests, symptoms and relevant treatment). * Aged 18-75 years. * Mentally competent to understand and follow medical recommendations. Exclusion Criteria: * Under 18 years of age. * Unable to provide consent. * Unstable concurrent disease.
Where this trial is running
Tel Aviv
- Tel-Aviv Sourasky Medical Center — Tel Aviv, Israel (Recruiting)
Study contacts
- Study coordinator: Ophir Freund, MD
- Email: Ophirf@tlvmc.gov.il
- Phone: +972-545-305648
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.